Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " Remarks on reporting and recording consistent with the ICRU Reference Dose. | BioMed Central Radiation Oncology Research Remarks on reporting and recording consistent with the ICRU Reference Dose Klaus Bratengeier Markus Oechsner Mark Gainey and Michael Flentje Open Access Address Klinik und Poliklinik fur Strahlentherapie University of Wurzburg Josef-Schneider-Str. 11 97080 Wurzburg Germany Email Klaus Bratengeier - Bratengeier_K@ Markus Oechsner - Oechsner_M@ Mark Gainey-Gainey_M@ Michael Flentje - Flentje_M@ Corresponding author Published 14 October 2009 Received 22 July 2009 Accepted 14 October 2009 Radiation Oncology 2009 4 44 doi 1748-717X-4-44 This article is available from http content 4 1 44 2009 Bratengeier et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background ICRU 50 62 provides a framework to facilitate the reporting of external beam radiotherapy treatments from different institutions. A predominant role is played by points that represent the PTV dose . However for new techniques like Intensity Modulated Radiotherapy IMRT - especially step and shoot IMRT - it is difficult to define a point whose dose can be called characteristic of the PTV dose distribution. Therefore different volume based methods of reporting of the prescribed dose are in use worldwide. Several of them were compared regarding their usability for IMRT and compatibility with the ICRU Reference Point dose for conformal radiotherapy CRT in this study. Methods The dose distributions of 45 arbitrarily chosen volumes treated by CRT plans and 57 volumes treated by IMRT plans were used for comparison. Some of the IMRT methods distinguish the planning target volume PTV and its central part .